Mayada Metwally
Sydney, NSW 2145, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease.
Journal: Science translational medicine
Published: April 03, 2024
Translation Reprogramming as a Novel Therapeutic Target in MAFLD.
Journal: Advanced biology
Published: November 08, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease.
Journal: EBioMedicine
Published: May 23, 2021
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 30, 2020
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2.
Journal: The Journal of pathology
Published: March 29, 2020
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.
Journal: Hepatology (Baltimore, Md.)
Published: June 11, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis.
Journal: Scientific reports
Published: September 06, 2018
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.
Journal: Scientific reports
Published: May 25, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.
Journal: Journal of hepatology
Published: May 22, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.
Journal: Alimentary pharmacology & therapeutics
Published: January 16, 2018
Last Updated: 09/26/2026